Novartis, Roche and Merck top the list of biopharmaceutical companies that spent the most money on research and development last year, followed by Pfizer, Johnson & Johnson and Sanofi.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Assistant Vice President - Dental Director||
|Vice President of Finance||
Urban Health Plan, Inc.